Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. [electronic resource]
Producer: 19920528Description: 706-17 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Reoperation
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.